Craft

Advanced
  • Home
  •  / Solasia Pharma
Solasia Pharma

Solasia Pharma

Revenue

¥429 M

FY, 2025

Solasia Pharma Summary

Company Summary

Overview
Solasia Pharma is a pharmaceutical company developing medicines for cancer. It is also engaged in the marketing, import, and export of pharmaceutical products and medical devices.
Type
Public
Status
Active
Founded
2006
HQ
Minato City, JP | view all locations
Website
http://solasia.co.jp/en/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Yoshihiro Arai

    Yoshihiro Arai, President and Chief Executive Officer, Board Member

    • Toshio Miyashita, Chief Financial Officer, Director, Board Member

      LocationsView all

      2 locations detected

      • Minato City, Tōkyō-to HQ

        Japan

        2-chōme-11-1 Shibakōen

      • Guangzhou

        China

        China Plaza, Yuexiu District

      Solasia Pharma Financials

      Summary Financials

      Revenue (FY, 2025)
      ¥429.0M
      Gross profit (FY, 2025)
      ¥245.0M
      Net income (FY, 2025)
      (¥876.0M)
      Cash (FY, 2025)
      ¥1.4B
      EBIT (FY, 2025)
      (¥860.0M)

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX